Clinical Trial

A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to compare 2 different versions cagrilintide and see how these work in people living with excess body weight. Participant will get either cagrilintide B or cagrilintide D injections. Which treatment participant will get is decided by chance. Participant will be in this clinical study for about 14 weeks.
Protocol Amendment History 1 change
critical Trial status changed: NOT_YET_RECRUITING → ACTIVE_NOT_RECRUITING 2026-07-10
Trial Details
NCT Number NCT07605052
Lead Sponsor Novo Nordisk A/S
Conditions Overweight, Obesity
Enrollment 50 participants
Start Date 2026-05-20
Primary Completion 2026-09-03 (estimated)
Study Completion 2026-09-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-09